Free Trial

Zentek (CVE:ZEN) Stock Passes Below 200 Day Moving Average - Here's What Happened

Zentek logo with Medical background

Zentek Ltd. (CVE:ZEN - Get Free Report)'s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$1.67 and traded as low as C$1.46. Zentek shares last traded at C$1.46, with a volume of 41,455 shares trading hands.

Zentek Stock Down 2.7%

The company has a market cap of C$149.99 million, a PE ratio of -13.78 and a beta of 0.77. The firm has a 50-day simple moving average of C$1.97 and a two-hundred day simple moving average of C$1.67. The company has a debt-to-equity ratio of 4.97, a current ratio of 2.06 and a quick ratio of 7.59.

Insiders Place Their Bets

In other Zentek news, Senior Officer Colin Stuart Van Der Kuur sold 15,000 shares of the company's stock in a transaction dated Thursday, May 8th. The shares were sold at an average price of C$2.20, for a total value of C$33,000.00. Insiders own 6.01% of the company's stock.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Zentek Right Now?

Before you consider Zentek, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.

While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines